Abeona Therapeutics Inc. (ABEO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5401-0.0799 (-4.93%)
As of 2:16PM EST. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 1.6200 |
| Open | 1.6400 |
| Bid | 1.5300 x 3200 |
| Ask | 1.5400 x 3200 |
| Day's Range | 1.5000 - 1.6500 |
| 52 Week Range | 0.9900 - 5.1900 |
| Volume | 2,533,560 |
| Avg. Volume | 2,273,525 |
| Market Cap | 151.742M |
| Beta (5Y Monthly) | 1.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.0150 |
| Earnings Date | Nov 10, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.40 |
- Zacks
Verastem (VSTM) Begins Phase II Combo Study for Ovarian Cancer
Verastem (VSTM) initiates phase II registration-directed study of VS-6766 and defactinib in patients with recurrent low-grade serous ovarian cancer.
- Zacks
Is the Options Market Predicting a Spike in Abeona (ABEO) Stock?
Investors need to pay close attention to Abeona (ABEO) stock based on the movements in the options market lately.
- Zacks
HorizonTherapeutics (HZNP) Rises YTD on Approvals & Buyouts
Horizon Therapeutics (HZNP) expects continued strong growth for Krystexxa and Tepezza in 2021. It is making efforts to expand the label for its marketed drugs.
© 2020 Verizon Media. All rights reserved.
